Abvc Biopharma (ABVC) Receivables (2018 - 2024)
Historic Receivables for Abvc Biopharma (ABVC) over the last 10 years, with Q3 2024 value amounting to $1.2 million.
- Abvc Biopharma's Receivables rose 9266.42% to $1.2 million in Q3 2024 from the same period last year, while for Sep 2024 it was $1.2 million, marking a year-over-year increase of 9266.42%. This contributed to the annual value of $842650.0 for FY2023, which is 3371.03% down from last year.
- Abvc Biopharma's Receivables amounted to $1.2 million in Q3 2024, which was up 9266.42% from $1.4 million recorded in Q2 2024.
- In the past 5 years, Abvc Biopharma's Receivables ranged from a high of $1.4 million in Q2 2024 and a low of $4083.0 during Q1 2024
- Its 5-year average for Receivables is $525181.2, with a median of $431699.0 in 2022.
- Its Receivables has fluctuated over the past 5 years, first crashed by 9713.74% in 2023, then soared by 1142237.42% in 2024.
- Abvc Biopharma's Receivables (Quarter) stood at $303147.0 in 2020, then soared by 40.56% to $426091.0 in 2021, then skyrocketed by 198.33% to $1.3 million in 2022, then tumbled by 33.71% to $842650.0 in 2023, then skyrocketed by 43.11% to $1.2 million in 2024.
- Its Receivables stands at $1.2 million for Q3 2024, versus $1.4 million for Q2 2024 and $4083.0 for Q1 2024.